The Orphan G Protein-coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
GPR41 and GPR43 are related members of a homologous family of orphan G protein-coupled receptors that are tandemly encoded at a single chromosomal locus in both humans and mice. We identified the acetate anion as an agonist of human GPR43 during routine ligand bank screening in yeast. This activity was confirmed after transient transfection of GPR43 into mammalian cells using Ca(2+) mobilization and [(35)S]guanosine 5'-O-(3-thiotriphosphate) binding assays and by coexpression with GIRK G protein-regulated potassium channels in Xenopus laevis oocytes. Other short chain carboxylic acid anions such as formate, propionate, butyrate, and pentanoate also had agonist activity. GPR41 is related to GPR43 (52% similarity; 43% identity) and was activated by similar ligands but with differing specificity for carbon chain length, with pentanoate being the most potent agonist. A third family member, GPR42, is most likely a recent gene duplication of GPR41 and may be a pseudogene. GPR41 was expressed primarily in adipose tissue, whereas the highest levels of GPR43 were found in immune cells. The identity of the cognate physiological ligands for these receptors is not clear, although propionate is known to occur in vivo at high concentrations under certain pathophysiological conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Molecular data showed that acetate, propionate, and butyrate can preferentially activate a series of free fatty acid receptors (FFARs) to increase energy harvest and triglyceride storage in adipose tissue [34,35,36].”
From Preventive Effects and Mechanisms of Garlic on Dyslipidemia and Gut Microbiome Dysbiosis (2019) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFAs can activate several G-protein coupled receptors (GPCR), of which free fatty acid receptor 2 (FFAR2, also referred to as GPR43) and 3 (FFAR3, also referred to as GPR41) are the most investigated (Brown et al., 2003;Le Poul et al., 2003;Nilsson et al., 2003).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Brown et al., 2003
Experimental — accuracy not yet measuredIn the citing paper
“As most SCFAs have agonist activity for GPR41 and GPR4341”
From Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer (2021) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
The Genome Sequence of Drosophila melanogaster
Adams, M. D., Celniker, S. E., Holt, R. A., Evans, C. A., Gocayne, J. D., Amanatides, P. G., Scherer, S. E., Li, P. W., Hoskins, R. A., Galle, R. F., et al. (2000) · Science · doi:10.1126/science.287.5461.2185 · Cited by 5,929
Genome Sequence of the Nematode C. elegans : A Platform for Investigating Biology
The C. elegans Sequencing Consortium* (1998) · Science · doi:10.1126/science.282.5396.2012 · Cited by 4,485
Mumberg, D., Müller, R., & Funk, M. (1995) · Gene · doi:10.1016/0378-1119(95)00037-7 · Cited by 1,957
Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ Receptor
Tatemoto, K., Hosoya, M., Habata, Y., Fujii, R., Kakegawa, T., Zou, M.-X., Kawamata, Y., Fukusumi, S., Hinuma, S., Kitada, C., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9489 · Cited by 1,685
Molecular tinkering of G protein-coupled receptors: an evolutionary success
Bockaert, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1723 · Cited by 1,550
The Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids
Briscoe, C. P., Tadayyon, M., Andrews, J. L., Benson, W. G., Chambers, J. K., Eilert, M. M., Ellis, C., Elshourbagy, N. A., Goetz, A. S., Minnick, D. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211495200 · Cited by 1,104
Self-citationA G Protein-coupled Receptor for UDP-glucose
Chambers, J. K., Macdonald, L. E., Sarau, H. M., Ames, R. S., Freeman, K., Foley, J. J., Zhu, Y., McLaughlin, M. M., Murdock, P., McMillan, L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10767 · Cited by 342
Self-citation
Research works printed but not linked: 1
- Rammal, 1991, Onkologie, 14, 130
Cited by
Items 601–700 of 1,005
Biological functions of SLC5A8, a candidate tumour suppressor
Ganapathy, V., Gopal, E., Miyauchi, S., & Prasad, P. D. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330237 · Cited by 99
Ang, Z., Er, J. Z., Tan, N. S., Lu, J., Liou, Y.-C., Grosse, J., & Ding, J. L. (2016) · Scientific Reports · doi:10.1038/srep34145 · Cited by 100
“While FFAR2 and FFAR3 can be activated by acetate, propionate and butyrate 4–6 , our studies were performed with acetate to avoid known off-target effects since both butyrate and propionate reportedly inhibit histone deacetylases 56 while butyrate also activates GPR109A 57 .”
InfluentialIdentification and characterization of the bovine G protein-coupled receptor GPR41 and GPR43 genes
Wang, A., Gu, Z., Heid, B., Akers, R. M., & Jiang, H. (2009) · Journal of Dairy Science · doi:10.3168/jds.2009-2037 · Cited by 98
“This mirrors both human and rodent GPR41 and GPR43 mRNA results (Brown et al., 2003; Le Poul et al., 2003; Hong et al., 2005).”
Borthakur, A., Priyamvada, S., Kumar, A., Natarajan, A. A., Gill, R. K., Alrefai, W. A., & Dudeja, P. K. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00308.2012 · Cited by 101
“Sensing of SCFAs in different tissues may be mediated by GPCRs, GPR41, and GPR43, which have been identified as SCFA receptors by the agonist’s selectivity in gene-transfected mammalian cells (3, 18).”
BackgroundInfluentialGut Microbial-Derived Short Chain Fatty Acids: Impact on Adipose Tissue Physiology
May, K. S., & den Hartigh, L. J. (2023) · Nutrients · doi:10.3390/nu15020272 · Cited by 95
“In terms of specificity, FFAR2 displays a dual coupling through Gi/o and pertussis toxin-insensitive Gq protein, further influencing cyclic adenosine monophosphate (cAMP), the extracellular signal-regulated protein kinase 1/2 (ERK1/2) cascade, and calcium channels, whereas FFAR3 couples exclusively with the Gi/o prote…”
BackgroundInfluentialObesity and the gut microbiome: Striving for causality
Harley, I. T. W., & Karp, C. L. (2012) · Molecular Metabolism · doi:10.1016/j.molmet.2012.07.002 · Cited by 96
“On the energy intake side of the equation, mice deficient in ffar3 (GRP41), a receptor for a variety of short chain fatty acids [11], are protected from obesity in the absence of microbiota, but not in the presence a conventionalized microbiota or a reductive model thereof [110].”
BackgroundLiu, H., Hou, C., Wang, G., Jia, H., Yu, H., Zeng, X., Thacker, P. A., Zhang, G., & Qiao, S. (2017) · Nutrients · doi:10.3390/nu9060559 · Cited by 95
“GPR41 (Free Fatty Acid Receptor 3, FFA3) and GPR43 (FFA2) are related G Protein-Coupled Receptors that are activated by short chain carboxylic acids [46,47].”
BackgroundGut Dysfunction and Non-alcoholic Fatty Liver Disease
Grabherr, F., Grander, C., Effenberger, M., Adolph, T. E., & Tilg, H. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00611 · Cited by 96
“SCFAs are metabolically highly active, mainly act via GPCRs, such as Gpr41 with its ligand propionate (53).”
BackgroundHow important are fatty acids in human health and can they be used in treating diseases?
Dicks, L. M. T. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2420765 · Cited by 108
“62 GABA is the most abundant neurotransmitter in the CNS of mammals and is co-transmitted with acetylcholine (ACH).”
BackgroundNagasaki, H., Kondo, T., Fuchigami, M., Hashimoto, H., Sugimura, Y., Ozaki, N., Arima, H., Ota, A., Oiso, Y., & Hamada, Y. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.01.001 · Cited by 93
Inoue, D., Kimura, I., Wakabayashi, M., Tsumoto, H., Ozawa, K., Hara, T., Takei, Y., Hirasawa, A., Ishihama, Y., & Tsujimoto, G. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.021 · Cited by 99
Nutrient sensing and signalling by the gut
Rasoamanana, R., Darcel, N., Fromentin, G., & Tomé, D. (2012) · Proceedings of the Nutrition Society · doi:10.1017/s0029665112000110 · Cited by 87
Tomita, T., Masuzaki, H., Iwakura, H., Fujikura, J., Noguchi, M., Tanaka, T., Ebihara, K., Kawamura, J., Komoto, I., Kawaguchi, Y., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0193-8 · Cited by 107
“Several investigators have recently demonstrated that fatty acids act as ligands for membrane-bound G-proteincoupled receptors such as GPR40 [3, 6, 7], GPR41, GPR43 [8, 9] and GPR120 [10].”
BackgroundThe incretin hormone GLP‐1 and mechanisms underlying its secretion: 肠促胰岛素激素GLP‐1及其潜在的分泌机制
Tian, L., & Jin, T. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12439 · Cited by 94
Role of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases
Rasouli‐Saravani, A., Jahankhani, K., Moradi, S., Gorgani, M., Shafaghat, Z., Mirsanei, Z., Mehmandar‐Oskuie, A., & Mirzaei, R. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114620 · Cited by 106
New Insights into Fatty Acid Modulation of Pancreatic β‐Cell Function
Haber, E. P., Procópio, J., Carvalho, C. R. D. O., Carpinelli, Â. R., Newsholme, P., & Curi, R. (2006) · International review of cytology · doi:10.1016/s0074-7696(06)48001-3 · Cited by 110
Molecular mechanisms of incretin hormone secretion
Ezcurra, M., Reimann, F., Gribble, F. M., & Emery, E. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.08.013 · Cited by 88
“FFAR2 can couple to Gq-signalling pathway and Gi/o-signalling pathway, whilst FFAR3 seems to lack a Gq component [28 ].”
L oss of FFAR 2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors
Pan, P., Oshima, K., Huang, Y., Agle, K. A., Drobyski, W. R., Chen, X., Zhang, J., Yearsley, M., Yu, J., & Wang, L. (2018) · International Journal of Cancer · doi:10.1002/ijc.31366 · Cited by 101
“FFAR1 and GPR120 respond to long-chain fatty acids; GPR84 is activated by medium-chain fatty acids18; while FFAR2 and FFAR3, sharing 43% of their amino acids in common, are the two main receptors for SCFAs.19 FFAR3 is expressed in adipose tissue, while FFAR2 is highly expressed in colonic epithelial cells,20 colonic n…”
BackgroundLi, T.-T., Tong, A.-J., Liu, Y.-Y., Huang, Z.-R., Wan, X.-Z., Pan, Y.-Y., Jia, R.-B., Liu, B., Chen, X.-H., & Zhao, C. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.06.005 · Cited by 97
Mutalipassi, M., Riccio, G., Mazzella, V., Galasso, C., Somma, E., Chiarore, A., de Pascale, D., & Zupo, V. (2021) · Marine Drugs · doi:10.3390/md19040227 · Cited by 105
Regulation of Energy Homeostasis by GPR41
Inoue, D., Tsujimoto, G., & Kimura, I. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00081 · Cited by 93
“Recently, a G-protein-coupled receptor deorphanizing strategy successfully identified GPR41 (also called free fatty acid receptor 3 or FFAR3) as a receptor for SCFAs.”
BackgroundInfluentialHan, J., Kim, I., Jung, S., Lee, S.-G., Son, H., & Myung, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095268 · Cited by 107
“In human skeletal muscle, GPR41 mRNA was detected and the amount was lower than that of adipose tissue [14].”
BackgroundFermented carrot juice attenuates type 2 diabetes by mediating gut microbiota in rats
Hu, R., Zeng, F., Wu, L., Wan, X., Chen, Y., Zhang, J., & Liu, B. (2019) · Food & Function · doi:10.1039/c9fo00475k · Cited by 104
Melhem, H., Kaya, B., Ayata, C. K., Hruz, P. L., & Niess, J. H. (2019) · Cells · doi:10.3390/cells8050450 · Cited by 102
“GPR41 is mainly activated by propionate, acetate, caproate, butyrate, and valerate to a lesser degree [85].”
BackgroundEffects of high fat diet on GPR109A and GPR81 gene expression
Wanders, D., Graff, E. C., & Judd, R. L. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.082 · Cited by 96
Short‐chain fatty acid sensing in rat duodenum
Akiba, Y., Inoue, T., Kaji, I., Higashiyama, M., Narimatsu, K., Iwamoto, K., Watanabe, M., Guth, P. H., Engel, E., Kuwahara, A., et al. (2015) · The Journal of Physiology · doi:10.1113/jphysiol.2014.280792 · Cited by 93
Weston, C., Winfield, I., Harris, M., Hodgson, R., Shah, A., Dowell, S. J., Mobarec, J. C., Woodlock, D. A., Reynolds, C. A., Poyner, D. R., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.751362 · Cited by 95
“cerevisiae dual reporter strains expressing chimeras of yeast GPA1(1– 467) (GPA1/G ) with the five C-terminal amino acids of 11 human G proteins representing G s, G 16, G q, G o, G i1/2, G i3, G z, G 12, G 13, and G 14 (MMY84 –MMY93) were used in this study (52).”
MethodSelf-citationButyrate and other short-chain fatty acids increase the rate of lipolysis in 3T3-L1 adipocytes
Rumberger, J. M., Arch, J. R. S., & Green, A. (2014) · PeerJ · doi:10.7717/peerj.611 · Cited by 90
“, 2003; Kruh, 1982), which is consistent with effects we observed on lipolysis, whereas for GPCR activation the relative order is acetate > propionate > butyrate GPR43 (Brown et al., 2003)).”
BackgroundInfluentialA cross-talk between gut microbiome, salt and hypertension
Naqvi, S., Asar, T. O., Kumar, V., Al-Abbasi, F. A., Alhayyani, S., Kamal, M. A., & Anwar, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111156 · Cited by 99
Interactions between the microbiota and enteric nervous system during gut-brain disorders
Fried, S. G., Wemelle, E., Cani, P. D., & Knauf, C. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108721 · Cited by 102
Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease
Pandey, H., Jain, D., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Intestinal Research · doi:10.5217/ir.2023.00080 · Cited by 100
“219 The binding of SC-FAs with GPR43 reduces inflammation.”
BackgroundMaternal gut microbiota in the health of mothers and offspring: from the perspective of immunology
Lu, X., Shi, Z., Jiang, L., & Zhang, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1362784 · Cited by 114
Microbiota and the control of blood-tissue barriers
Al-Asmakh, M., & Hedin, L. (2015) · Tissue Barriers · doi:10.1080/21688370.2015.1039691 · Cited by 93
Joseph, J., Depp, C., Shih, P.-A. B., Cadenhead, K. S., & Schmid-Schönbein, G. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00155 · Cited by 95
“GPR43 expression has primarily been observed in the colon, ileum, adipose tissue, and immune cells especially monocytes and neutrophils (Brown et al., 2003; Le Poul et al., 2003; Nilsson et al., 2003).”
BackgroundImplication of G Protein-Coupled Receptor 43 in Intestinal Inflammation: A Mini-Review
Yang, G., Chen, S., Deng, B., Tan, C., Deng, J., Zhu, G., Yin, Y., & Ren, W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01434 · Cited by 103
“It could be activated by SCFAs, with acetate and propionate serve as the most potent activators followed by butyrate and other SCFAs (32, 33).”
BackgroundDo SCFA have a role in appetite regulation?
Darzi, J., Frost, G. S., & Robertson, M. D. (2011) · Proceedings of the Nutrition Society · doi:10.1017/s0029665110004039 · Cited by 94
“FFA2 and FFA3 are expressed in a variety of tissues including adipose and the colon((21,22,26,27)).”
BackgroundHansen, C. H. F., Frøkiær, H., Christensen, A., Bergström, A., Licht, T. R., Hansen, A. K., & Metzdorff, S. B. (2013) · Journal of Nutrition · doi:10.3945/jn.112.172361 · Cited by 102
“Of particular interest is GPR43, which is present on neutrophils and monocytes (9).”
BackgroundIntestinal microbiota could transfer host Gut characteristics from pigs to mice
Diao, H., Yan, H., Xiao, Y., Yu, B., Yu, J., He, J., Zheng, P., Zeng, B., Wei, H., Mao, X., et al. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0851-z · Cited by 104
Tocchetti, C. G., Ameri, P., de Boer, R. A., D’Alessandra, Y., Russo, M., Sorriento, D., Ciccarelli, M., Kiss, B., Bertrand, L., Dawson, D. K., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa222 · Cited by 100
Short-Chain Fatty Acid and FFAR2 Activation – A New Option for Treating Infections?
Schlatterer, K., Peschel, A., & Kretschmer, D. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.785833 · Cited by 98
“The G-proteins Gaq and Gai/o show affinity to the N-terminal G-protein binding site of FFAR2 (Brown et al., 2003), which is known to initiate different signaling cascades.”
BackgroundInfluentialThe effect of short-chain fatty acids on M2 macrophages polarizationin vitroandin vivo
Huang, C., Du, W., Ni, Y., Lan, G., & Shi, G. (2021) · Clinical & Experimental Immunology · doi:10.1093/cei/uxab028 · Cited by 99
“SCFAs act through binding to endogenous receptors GPR41 and GPR43, which have been reported to be expressed in the gut epithelium [49, 50], adipose tissues [51](p43),[52], immune cells [53], and nervous system [54, 55].”
BackgroundPharmacology and physiology of gastrointestinal enteroendocrine cells
Mace, O. J., Tehan, B., & Marshall, F. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.155 · Cited by 91
“Short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate, accumulate in the lower intestine as a result of the microbial fermentation of nondigestible carbohydrates.”
BackgroundInfluentialSelf-citationUnger, A. L., Torres-Gonzalez, M., & Kraft, J. (2019) · Nutrients · doi:10.3390/nu11092200 · Cited by 89
“Butyric acid (4:0; Figure 2a) is hallmarked as an inhibitor of histone deacetylase [71–73] and an agonist of specific G protein-coupled receptors [74,75].”
BackgroundButyric Acid and Leucine Induce α-Defensin Secretion from Small Intestinal Paneth Cells
Takakuwa, A., Nakamura, K., Kikuchi, M., Sugimoto, R., Ohira, S., Yokoi, Y., & Ayabe, T. (2019) · Nutrients · doi:10.3390/nu11112817 · Cited by 102
“SCFAs, produced by the intestinal microbiota, act as host energy sources and as signaling molecules via GPCR [22,23].”
BackgroundChenghan, M., Li, W., Zhao, B., He, Y., Li, Q., Zhang, T., Xiaojie, L., Zhang, K., Yingqian, Z., & Zhong, Z. (2025) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15299 · Cited by 98
“64,72 Among the various SCFAs, acetate and propionate are the preferred ligands for FFAR2, while FFAR3 has a stronger binding affinity to butyrate.”
The gut microbiome and hypertension
Pevsner‐Fischer, M., Blacher, E., Tatirovsky, E., Ben‐Dov, I. Z., & Elinav, E. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000293 · Cited by 93
Cereal fiber, fruit fiber, and type 2 diabetes: Explaining the paradox
Davison, K., & Temple, N. J. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.11.002 · Cited by 102
Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
Paternoster, S., & Falasca, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00584 · Cited by 91
“In pancreatic β-cells, both GPR43 and GPR41 are expressed, and the latter antagonizes GSIS (304).”
BackgroundInfluentialShort-chain fatty acids and FFAR2 as suppressors of bone resorption
Montalvany-Antonucci, C. C., Duffles, L. F., de Arruda, J. A. A., Zicker, M. C., de Oliveira, S., Macari, S., Garlet, G. P., Madeira, M. F. M., Fukada, S. Y., Andrade, I., et al. (2019) · Bone · doi:10.1016/j.bone.2019.05.016 · Cited by 96
Lima, J., Auffret, M. D., Stewart, R. D., Dewhurst, R. J., Duthie, C.-A., Snelling, T. J., Walker, A. W., Freeman, T. C., Watson, M., & Roehe, R. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00701 · Cited by 103
Busnelli, M., Manzini, S., & Chiesa, G. (2019) · Nutrients · doi:10.3390/nu12010079 · Cited by 98
Gut microbial metabolites alter IgA immunity in type 1 diabetes
Huang, J., Pearson, J. A., Peng, J., Hu, Y., Sha, S., Xing, Y., Huang, G., Li, X., Hu, F., Xie, Z., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.135718 · Cited by 96
“Although SCFAs were reported to induce intracellular signaling changes by activating the orphan metabolite-sensing G-Protein Receptor (GPR41) and GPR43 (29), we did not find any changes in Gpr41 or Gpr43 expression between acetate-treated and non-acetate-treated donor B cells (Figure 8A-B).”
BackgroundPropionate Enhances Cell Speed and Persistence to Promote Intestinal Epithelial Turnover and Repair
Bilotta, A. J., Ma, C., Yang, W., Yu, Y., Yu, Y., Zhao, X., Zhou, Z., Yao, S., Dann, S. M., & Cong, Y. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.11.011 · Cited by 99
“Thus, our findings support the argument that both cell speed and persistence are linked to cell migration.38 Propionate exerts its actions on cells via G-coupled protein receptors and by acting as an inhibitor for HDAC.41,44 Here we found that HDAC inhibition and GPR43 mediated propionate-induced cell speed and persis…”
BackgroundDietary fatty acids in gut health: Absorption, metabolism and function
Xu, E., Chen, C., Fu, J., Zhu, L., Shu, J., Jin, M., Wang, Y., & Zong, X. (2021) · Animal nutrition · doi:10.1016/j.aninu.2021.09.010 · Cited by 96
Gut microbiota and allergic diseases in children
Akagawa, S., & Kaneko, K. (2022) · Allergology International · doi:10.1016/j.alit.2022.02.004 · Cited by 106
Caetano, M. A. F., & Castelucci, P. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i28.9985 · Cited by 98
The role of polyunsaturated fatty acids and GPR40 receptor in brain
Khan, M. Z., & He, L. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.013 · Cited by 101
“Both GPR41 and GPR43 are activated by short chain fatty acids such as formate, acetate, propionate, butyrate and pentanoate (Brown et al., 2003 ; Nilsson et al., 2003).”
BackgroundRoadblocks in the gut: barriers to enteric infection
Gill, N., Wlodarska, M., & Finlay, B. B. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01578.x · Cited by 87
“Butyrate production has been implicated in a feedback mechanism that is involved in upregulating mucus production by epithelial cells, providing additional attachment sites (Brown et al., 2003; Burger-van Paassen et al., 2009).”
BackgroundThe first synthetic agonists of FFA2: Discovery and SAR of phenylacetamides as allosteric modulators
Wang, Y., Jiao, X., Kayser, F., Liu, J., Wang, Z., Wanska, M., Greenberg, J., Weiszmann, J., Ge, H., Tian, H., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.112 · Cited by 96
Sasaki, S., Kitamura, S., Negoro, N., Suzuki, M., Tsujihata, Y., Suzuki, N., Santou, T., Kanzaki, N., Harada, M., Tanaka, Y., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101405t · Cited by 98
Oh, D. Y., & Lagakos, W. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283479230 · Cited by 100
Weill, N., & Rognan, D. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800447g · Cited by 95
The microbiota-gut-brain axis: Focus on the fundamental communication pathways
(2020) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2020.08.012 · Cited by 88
Duan, W.-X., Wang, F., Liu, J., & Liu, C. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01123-9 · Cited by 95
“FFAR2 and FFAR3 are abundant in immune cells, adipose tissue, intestine, and bone marrow [24–26].”
BackgroundLu, D., He, A., Tan, M., Mrad, M., Daibani, A. E., Hu, D., Liu, X., Kleiboeker, B. A., Che, T., Hsu, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48471-2 · Cited by 99
“GPR41 and GPR43 are activated by short-chain fatty acids, such as butyrate, propionate, and acetate 30 , while GPR84 is activated by medium-chain fatty acids 31 .”
Tikhonova, I. G., Sum, C. S., Neumann, S., Thomas, C. J., Raaka, B. M., Costanzi, S., & Gershengorn, M. C. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0614782 · Cited by 97
Nakamoto, K., Nishinaka, T., Sato, N., Mankura, M., Kōyama, Y., Kasuya, F., & Tokuyama, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081563 · Cited by 98
“Accumulating evidence clearly shows that free fatty acids (FFAs) can act as ligands for several G-protein-coupled receptors (GPCR), including GPR41 [10], GPR43 [10], GPR84 [11], GPR40 [12] and GPR120 [13].”
BackgroundYan, H., & Ajuwon, K. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145940 · Cited by 90
“We determined that butyrate-treated cells had a higher FFAR3 and lower FFAR2 expression (Fig 9A).”
BackgroundInfluentialFaecalibacterium prausnitzii phylotypes in type two diabetic, obese, and lean control subjects
Hippe, B., Remely, M., Aumueller, E., Pointner, A., Magnet, U., & Haslberger, A. G. (2016) · Beneficial Microbes · doi:10.3920/bm2015.0075 · Cited by 86
Anastasovska, J., Arora, T., Canon, G. J. S., Parkinson, J. R. C., Touhy, K., Gibson, G. R., Nadkarni, N. A., So, P., Goldstone, A. P., Thomas, E. L., et al. (2012) · Obesity · doi:10.1038/oby.2012.6 · Cited by 86
“There is an indication that the SCFA receptor FFAR3 is present in the brain (39).”
BackgroundAlexander, S., Mathie, A. A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_3.x · Cited by 93
The emerging role of microbiota-derived short-chain fatty acids in immunometabolism
Jasim, S. A., Opulencia, M. J. C., Ramírez‐Coronel, A. A., Abdelbasset, W. K., Abed, M. H., Markov, A. A., Al‐Awsi, G. R. L., Shamsiev, J. A., Hammid, A. T., Shalaby, M. N., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108983 · Cited by 96
Qiu, Z., Qiao, Y., Zhang, B., Sun‐Waterhouse, D., & Zheng, Z. (2022) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12972 · Cited by 91
Soto-Guzmán, A., Robledo, T., Lopez-Pérez, M., & Salazar, E. P. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.003 · Cited by 96
Treatment of Type 2 Diabetes by Free Fatty Acid Receptor Agonists
Watterson, K. R., Hudson, B. D., Ulven, T., & Milligan, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00137 · Cited by 97
The short-chain fatty acid receptor, FFA2, contributes to gestational glucose homeostasis
Fuller, M. H., Priyadarshini, M., Gibbons, S. M., Angueira, A. R., Brodsky, M. R., Hayes, M. G., Kovatcheva‐Datchary, P., Bäckhed, F., Gilbert, J. A., Lowe, W. L., et al. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00171.2015 · Cited by 103
“These reciprocal changes may be important, since FFA2 is selective for acetate over propionate (8), and the proportional increase in acetate could further enhance FFA2 signaling and the -cell response.”
BackgroundResultG-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell
Morgan, N. G., & Dhayal, S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.07.020 · Cited by 101
“However, this is now thought to represent a pseudogene that is unlikely to be expressed as a functional protein [14].”
BackgroundDiet-induced Obesity Up-regulates the Abundance of GPR43 and GPR120 in a Tissue Specific Manner
Cornall, L. M., Mathai, M. L., Hryciw, D. H., & McAinch, A. J. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000335820 · Cited by 94
Hudson, B. D., Christiansen, E., Tikhonova, I. G., Grundmann, M., Kostenis, E., Adams, D. R., Ulven, T., & Milligan, G. (2012) · The FASEB Journal · doi:10.1096/fj.12-213314 · Cited by 96
“For this, it was tested across multiple functional endpoints, reflective of the range of known signaling pathways FFA2 is able to regulate (27).”
BackgroundIdentifying ligands at orphan GPCRs: current status using structure‐based approaches
Ngo, T., Kufareva, I., Coleman, J. L. J., Graham, R. M., Abagyan, R. A., & Smith, N. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13452 · Cited by 99
“Importantly, acetate activation of FFA2 via Gαi or Gαq was then confirmed by [ (35)S]-GTPγS binding and increases in [Ca] levels, respectively (Brown et al., 2003).”
BackgroundMethodInfluentialMucosal Immune Development in Early Life: Setting the Stage
Brugman, S., Perdijk, O., van Neerven, R. J. J., & Savelkoul, H. F. J. (2015) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-015-0329-y · Cited by 106
“Next to the GALT, the nasopharynx-associated lymphoid tissue (NALT), and bronchus-associated lymphoid tissue (BALT) are also part of the mucosal-associated lymphoid tissue.”
BackgroundInfluentialThe Potential Impact of Probiotics on the Gut Microbiome of Athletes
Wosinska, L., Cotter, P. D., O’Sullivan, Ó., & Guinane, C. M. (2019) · Nutrients · doi:10.3390/nu11102270 · Cited by 98
The Role of the Gut Microbiome in Energy Balance With a Focus on the Gut-Adipose Tissue Axis
Xiao, H., & Kang, S. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00297 · Cited by 82
“For example, Gpr43, which has a strong affinity to acetate and propionate, plays an important role in mediating the microbial input in WAT metabolism (Brown et al., 2003; Hong et al., 2005).”
BackgroundWu, Y., Wang, C., Wan, J., Yao, H., & Yuan, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136933 · Cited by 92
“As has been shown, SCFAs exert an antiinflammatory effect by inhibiting histone deacetylases and specific ligands for G-proteincoupled receptors (GPCRs) [104].”
BackgroundVeprik, A., Laufer, D., Weiss, S., Rubins, N., & Walker, M. D. (2016) · The FASEB Journal · doi:10.1096/fj.201500030r · Cited by 88
Li, Z., Qiu, Q., Geng, X., Yang, J., Huang, W., & Qian, H. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1189530 · Cited by 90
Biochemical Features of Beneficial Microbes: Foundations for Therapeutic Microbiology
Engevik, M. A., & Versalovic, J. A. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0012-2016 · Cited by 98
Liang, D., Zhang, L., Chen, H., Zhang, H., Hu, H., & Dai, X. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.02.209 · Cited by 94
Jayakumar, S., & Loomba, R. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15314 · Cited by 84
Eslick, S., Williams, E. J., Berthon, B. S., Wright, T., Karihaloo, C., Gately, M., & Wood, L. G. (2022) · Nutrients · doi:10.3390/nu14040765 · Cited by 89
“Evidence within the literature supports the ability of acetate to upregulate FFAR2 and FFAR3 receptors in human monocytes [16,34,35].”
BackgroundThe functional roles of short chain fatty acids as postbiotics in human gut: future perspectives
Ragavan, M. L., & Hemalatha, S. (2023) · Food Science and Biotechnology · doi:10.1007/s10068-023-01414-x · Cited by 89
“Ionised SCFA activates transmembrane receptors (GPR41) and fatty acid binding proteins like FFAR, and GPR109a, which then transmit signals to the nucleus via extracellular activity (Brown et al., 2003; Nohr et al., 2015).”
Expression of odorant receptor Olfr78 in enteroendocrine cells of the colon
Fleischer, J., Bumbalo, R., Bautze, V., Strotmann, J. M., & Breer, H. (2015) · Cell and Tissue Research · doi:10.1007/s00441-015-2165-0 · Cited by 96
Barathikannan, K., Chelliah, R., Rubab, M., Daliri, E. B., Elahi, F., Kim, D.-H., Agastian, P., Oh, S.-Y., & Oh, D. H. (2019) · Microorganisms · doi:10.3390/microorganisms7100456 · Cited by 89
“For example, by activating Gpr43 via dietary metabolite acetate, lipolysis in adipocytes was found to directly decrease, which is key to lowering plasma-free fatty acid levels.”
BackgroundInfluentialMicrobial Alterations and Risk Factors of Breast Cancer: Connections and Mechanistic Insights
Parida, S., & Sharma, D. (2020) · Cells · doi:10.3390/cells9051091 · Cited by 81
“The Immune System Bridges the Gut Microbiota with Systemic Energy Homeostasis: Focus on TLRs, Mucosal Barrier, and SCFAs.”
BackgroundInfluentialGut Microbial Metabolites and Blood Pressure Regulation: Focus on SCFAs and TMAO
Poll, B. G., Cheema, M. U., & Pluznick, J. L. (2020) · Physiology · doi:10.1152/physiol.00004.2020 · Cited by 89
Forbes, S., Stafford, S., Coope, G., Heffron, H., Real, K., Newman, R., Davenport, R., Barnes, M., Grosse, J., & Cox, H. (2015) · Diabetes · doi:10.2337/db15-0481 · Cited by 82
“Acetate and propionate exhibit a higher potency for FFA2 than FFA3, while butyrate and other SCFAs have a lower potency for both (8).”
BackgroundStoddart, L. A., Brown, A. J., & Milligan, G. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.031534 · Cited by 95
“Furthermore, the related receptor GPR41 that responds only to less hydrophobic, short-chain fatty acids (Brown et al., 2003) does not display high levels of apparent constitutive activity that can be eliminated by treatment with similar concentrations of fatty acid-free serum albumin.”
BackgroundSelf-citationTRPA1 Is a Polyunsaturated Fatty Acid Sensor in Mammals
Motter, A. L., & Ahern, G. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038439 · Cited by 85
“Further, enteroendocrine tissue express several orphan GPCRs: GPR40 [6], GPR41 [7,8], GPR43 [7,8] and GPR120 [9] that are believed to participate in the sensing of saturated and unsaturated fatty acids.”
BackgroundSynbiotics for Improved Human Health: Recent Developments, Challenges, and Opportunities
Krumbeck, J. A., Walter, J., & Hutkins, R. W. (2018) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030117-012757 · Cited by 84
“In addition, butyrate (among other SCFAs) has signaling capacities via G protein–coupled receptors (Brown et al. 2003, Kasubuchi et al. 2015, Krishnan et al. 2015, Tang et al. 2011, Tolhurst et al. 2012) and increases levels of anorectic hormones such as PYY and GLP-1 that contribute to energy…”
BackgroundDucastel, S., Touche, V., Trabelsi, M.-S., Boulinguiez, A., Butruille, L., Nawrot, M., Peschard, S., Chávez-Talavera, O., Dorchies, E., Vallez, E., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-56743-x · Cited by 84
Metadata
- Authors
- Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., Pike, N. B., Strum, J. C., Steplewski, K. M., Murdock, P. R., Holder, J. C., Marshall, F. H., Szekeres, P. G., Wilson, S., Ignar, D. M., Foord, S. M., Wise, A., & Dowell, S. J.
- Affiliations
- Research Triangle Park Foundation (US)
- Corresponding author
- Brown, Andrew J.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 278
- Issue
- 13
- Pages
- 11312-11319
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2035421462
- Cited by
- 2,409
- References
- 33
- Citations by year
- 2026: 164 · 2025: 167 · 2024: 140 · 2023: 174 · 2022: 179 · 2021: 184 · 2020: 172 · 2019: 153 · 2018: 149 · 2017: 99 · 2016: 150 · 2015: 114 · 2014: 95 · 2013: 86 · 2012: 86
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6422 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, cc-by)
- Funders
- GlaxoSmithKline
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Nursing › Nutrition and Dietetics › Biochemical Analysis and Sensing Techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- GPR41, GPR43, orphan G protein-coupled receptor, propionate, short-chain carboxylic acids, acetate, receptor agonists, gene duplication, pseudogenes, adipose tissue, immune cells, ligand identification
- MeSH terms
- Amino Acid Sequence, Animals, Carboxylic Acids, Humans, Immunohistochemistry, Molecular Sequence Data, Propionates, Receptors, Cell Surface, Recombinant Proteins, Xenopus laevis, DNA Primers, Receptors, G-Protein-Coupled
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.